These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10757089)

  • 21. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
    Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
    Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas and HLA antigens.
    Caronia S; McGarvey MJ; Goldin RD; Foster GR
    J Viral Hepat; 2004 Nov; 11(6):511-8. PubMed ID: 15500551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.
    Mundt B; Wirth T; Zender L; Waltemathe M; Trautwein C; Manns MP; Kühnel F; Kubicka S
    Gut; 2005 Nov; 54(11):1590-6. PubMed ID: 16227360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas system and apoptosis in viral hepatitis.
    Hayashi N; Mita E
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S223-6. PubMed ID: 9407341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.
    Agrati C; Nisii C; Oliva A; D'Offizi G; Montesano C; Pucillo LP; Poccia F
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):307-16. PubMed ID: 12455864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
    Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
    J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathogenesis in hepatitis C virus cirrhosis.
    Spengler U; Nattermann J
    Clin Sci (Lond); 2007 Feb; 112(3):141-55. PubMed ID: 17199558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line.
    Hahn CS; Cho YG; Kang BS; Lester IM; Hahn YS
    Virology; 2000 Oct; 276(1):127-37. PubMed ID: 11022001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular injury in hepatitis B and C virus infections.
    Feitelson MA
    Clin Lab Med; 1996 Jun; 16(2):307-24. PubMed ID: 8792074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
    Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
    J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.
    Ballardini G; De Raffele E; Groff P; Bioulac-Sage P; Grassi A; Ghetti S; Susca M; Strazzabosco M; Bellusci R; Iemmolo RM; Grazi G; Zauli D; Cavallari A; Bianchi FB
    Liver Transpl; 2002 Jan; 8(1):10-20. PubMed ID: 11799480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C.
    Liu DX
    Med Hypotheses; 2001 Mar; 56(3):405-8. PubMed ID: 11359371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.
    Tiegs G
    Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver.
    Ferenbach DA; Haydon GH; Rae F; Malcomson RD; Harrison DJ
    J Pathol; 1997 Nov; 183(3):299-304. PubMed ID: 9422985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C.
    Zaki Mel S; Auf FA; Ghawalby NA; Saddal NM
    Immunol Invest; 2008; 37(2):163-70. PubMed ID: 18300041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of hepatitis C virus recurrence in the liver allograft.
    McCaughan GW; Zekry A
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S7-S13. PubMed ID: 12362292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.